Yiran Li

1.5k total citations
44 papers, 596 citations indexed

About

Yiran Li is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Yiran Li has authored 44 papers receiving a total of 596 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 14 papers in Cancer Research and 13 papers in Oncology. Recurrent topics in Yiran Li's work include Cancer-related molecular mechanisms research (7 papers), Cancer Immunotherapy and Biomarkers (5 papers) and Circular RNAs in diseases (5 papers). Yiran Li is often cited by papers focused on Cancer-related molecular mechanisms research (7 papers), Cancer Immunotherapy and Biomarkers (5 papers) and Circular RNAs in diseases (5 papers). Yiran Li collaborates with scholars based in China, United States and Hong Kong. Yiran Li's co-authors include Yiding Bian, Xiaoping Wan, Kai Wang, Lanlan Fang, Yiping Yu, Yingpu Sun, Jiasheng Xu, Ruizhe Zhang, Huan Tong and Xiaoping Wan and has published in prestigious journals such as PLoS ONE, Scientific Reports and The Lancet Oncology.

In The Last Decade

Yiran Li

40 papers receiving 589 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yiran Li China 18 233 139 137 120 97 44 596
Haijuan Gu China 15 351 1.5× 206 1.5× 108 0.8× 148 1.2× 50 0.5× 29 866
Bastian Czogalla Germany 15 237 1.0× 103 0.7× 141 1.0× 176 1.5× 54 0.6× 64 620
Ryoichi Asaka Japan 15 297 1.3× 158 1.1× 71 0.5× 88 0.7× 45 0.5× 38 634
Ruibao Chen China 14 312 1.3× 106 0.8× 59 0.4× 50 0.4× 82 0.8× 32 609
Daniel J. Herr United States 16 307 1.3× 69 0.5× 48 0.4× 82 0.7× 45 0.5× 41 701
Han Li China 13 362 1.6× 234 1.7× 125 0.9× 55 0.5× 54 0.6× 43 593
Jiao Wang China 13 152 0.7× 38 0.3× 72 0.5× 183 1.5× 46 0.5× 37 621
Apriliana E. R. Kartikasari Australia 15 251 1.1× 69 0.5× 178 1.3× 180 1.5× 52 0.5× 25 789

Countries citing papers authored by Yiran Li

Since Specialization
Citations

This map shows the geographic impact of Yiran Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yiran Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yiran Li more than expected).

Fields of papers citing papers by Yiran Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yiran Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yiran Li. The network helps show where Yiran Li may publish in the future.

Co-authorship network of co-authors of Yiran Li

This figure shows the co-authorship network connecting the top 25 collaborators of Yiran Li. A scholar is included among the top collaborators of Yiran Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yiran Li. Yiran Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Men, Yuqin, Yiran Li, Yiran Li, et al.. (2025). Sulfonium lipid nanoparticles for intranasal mRNA delivery to lung epithelial and immune cells. Acta Biomaterialia. 205. 616–633.
2.
Qi, Peng, Tianliang Yao, Jian Zhu, et al.. (2025). Clinical-grade AI model for molecular subtyping of endometrial cancer: a multi-center cohort study in China. Molecular Biomedicine. 6(1). 102–102.
3.
Song, Shuang, Yinyan He, Huimin Wang, et al.. (2025). Unveiling immunogenic characteristics and neoantigens in endometrial cancer with POLE hotspot mutations for improved immunotherapy. Frontiers in Immunology. 16. 1528532–1528532. 1 indexed citations
4.
Sieber, Laura, Jesús García-López, Shiekh Tanveer Ahmad, et al.. (2024). Loss of Elp1 in cerebellar granule cell progenitors models ataxia phenotype of Familial Dysautonomia. Neurobiology of Disease. 199. 106600–106600.
6.
Li, Yiran, Tracy X. Cui, Jing Lei, et al.. (2024). Itaconate suppresses house dust mite-induced allergic airways disease and Th2 cell differentiation. Mucosal Immunology. 17(6). 1174–1183. 3 indexed citations
7.
Li, Yiran, Mingyuan Han, Shiuhyang Kuo, et al.. (2023). Tuft cells are required for a rhinovirus-induced asthma phenotype in immature mice. JCI Insight. 9(2). 7 indexed citations
8.
Lei, Ting, Xue Liu, Huijia Fu, et al.. (2023). Blockade of C5a receptor unleashes tumor-associated macrophage antitumor response and enhances CXCL9-dependent CD8+ T cell activity. Molecular Therapy. 32(2). 469–489. 34 indexed citations
9.
Gaetani, Massimiliano, Yiran Li, Zheng Xu, et al.. (2023). Distinct molecular targets of ProEGCG from EGCG and superior inhibition of angiogenesis signaling pathways for treatment of endometriosis. Journal of Pharmaceutical Analysis. 14(1). 100–114. 7 indexed citations
10.
Li, Yiran, Xiaojun Chen, Tao Wang, et al.. (2023). Cytokine patterns in the blister fluid and plasma of patients with fracture blisters. International Immunopharmacology. 123. 110738–110738. 5 indexed citations
11.
Han, Mingyuan, et al.. (2022). M2 Macrophages promote IL-33 expression, ILC2 expansion and mucous metaplasia in response to early life rhinovirus infections. Frontiers in Immunology. 13. 952509–952509. 12 indexed citations
12.
Song, Yunfeng, et al.. (2022). Therapeutic exosomes loaded with SERPINA5 attenuated endometrial cancer cell migration via the integrin β1/FAK signaling pathway. Cellular Oncology. 45(5). 861–872. 11 indexed citations
13.
Zeng, Yunxiang, et al.. (2022). Decreased Expression of a Novel lncRNA FAM181A-AS1 is Associated with Poor Prognosis and Immune Infiltration in Lung Adenocarcinoma. Pharmacogenomics and Personalized Medicine. Volume 15. 985–998. 23 indexed citations
14.
Li, Yiran, Yunfeng Song, Jian Huang, & Kai Wang. (2022). APC mutations as a predictive marker of endometrial cancer immunotherapy: a retrospective cohort study. The Lancet Oncology. 23. S9–S9. 4 indexed citations
15.
Hu, Jialing, et al.. (2021). Differential Expression of the TLR4 Gene in Pan-Cancer and Its Related Mechanism. Frontiers in Cell and Developmental Biology. 9. 700661–700661. 24 indexed citations
16.
Li, Yiran, Qizhi He, Shuangdi Li, et al.. (2020). <p><em>POLE</em> Mutation Characteristics in a Chinese Cohort with Endometrial Carcinoma</p>. OncoTargets and Therapy. Volume 13. 7305–7316. 8 indexed citations
17.
Li, Yiran, et al.. (2020). Advances in the role of miRNAs in the occurrence and development of osteosarcoma. Open Medicine. 15(1). 1003–1011. 3 indexed citations
18.
Fang, Lanlan, et al.. (2019). Upregulation of AREG, EGFR, and HER2 contributes to increased VEGF expression in granulosa cells of patients with OHSS†. Biology of Reproduction. 101(2). 426–432. 24 indexed citations
19.
Zhao, Rongjie, Yiran Li, Zhen Liu, et al.. (2018). Prognosis and nomogram for predicting postoperative survival of duodenal adenocarcinoma: A retrospective study in China and the SEER database. Scientific Reports. 8(1). 7940–7940. 31 indexed citations
20.
Li, Yiran, Li Wan, Binhua Liang, et al.. (2016). Identification of cancer risk lncRNAs and cancer risk pathways regulated by cancer risk lncRNAs based on genome sequencing data in human cancers. Scientific Reports. 6(1). 39294–39294. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026